In part 2 of the conversation with Dr. Luoma, he and Dan discuss the complexities of psychedelic research, including the regulatory hurdles and safety requirements that can complicate and increase costs. Dr. Luoma explores the promising psychedelics currently under investigation, such as psilocybin and MDMA, and emphasizes the importance of integration in making psychedelic experiences meaningful. Finally, Dr. Luoma gives an overview of the Portland Institute for Psychedelic Science, which aims to advance research and therapy in this field.

Dr. Jason Luoma is a researcher, practitioner, and co-founder of the Portland Institute for Psychadelic Science; the Portland Psychotherapy Clinic, Research, and Training Center; & host of the Research Matters Podcast.

Special Guest: Dr. Jason Luoma
https://jasonluoma.com/

The Portland Institute for Psychadelic Science
https://www.pipsinstitute.com/

Jason's Research Matters Podcast
https://jasonluoma.com/researchmatters/

💬 Click here to text the show!

🎞️ Video version of the show@PsychotherapyAppliedPsychology on YouTube
🛜 Check out the website: Listen to every episode on your podcast player of choice

Connect with Dan
☏ Leave a voice message on Speakpipe
🔗 LinkedIn
📬 [email protected]

🦋@danielwcox.bsky.social